XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $927,000 | -0.5% | 27,121 | +12.1% | 0.00% | – |
| Q2 2023 | $932,000 | +108.5% | 24,201 | +93.9% | 0.00% | – |
| Q1 2023 | $447,000 | -29.7% | 12,484 | -22.6% | 0.00% | – |
| Q4 2022 | $636,000 | – | 16,130 | +1612900.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2022 | $743,000 | -2.2% | 24,313 | 0.0% | 0.00% | – |
| Q4 2021 | $760,000 | +96.4% | 24,313 | -4.0% | 0.00% | – |
| Q3 2021 | $387,000 | -18.0% | 25,313 | -0.2% | 0.00% | – |
| Q2 2021 | $472,000 | +4.0% | 25,370 | 0.0% | 0.00% | – |
| Q1 2021 | $454,000 | -27.8% | 25,370 | -37.9% | 0.00% | – |
| Q4 2020 | $629,000 | +39.2% | 40,883 | +0.1% | 0.00% | – |
| Q3 2020 | $452,000 | -11.7% | 40,826 | 0.0% | 0.00% | – |
| Q2 2020 | $512,000 | +10.1% | 40,826 | -0.5% | 0.00% | – |
| Q1 2020 | $465,000 | -23.9% | 41,014 | -11.9% | 0.00% | – |
| Q4 2019 | $611,000 | -17.7% | 46,572 | -43.5% | 0.00% | – |
| Q3 2019 | $742,000 | +24.7% | 82,362 | +36.5% | 0.00% | – |
| Q2 2019 | $595,000 | +2.6% | 60,340 | +5.8% | 0.00% | – |
| Q1 2019 | $580,000 | +62.5% | 57,038 | +0.9% | 0.00% | – |
| Q4 2018 | $357,000 | -69.5% | 56,546 | -36.2% | 0.00% | – |
| Q3 2018 | $1,171,000 | +9.0% | 88,692 | -24.0% | 0.00% | – |
| Q2 2018 | $1,074,000 | +87.8% | 116,692 | 0.0% | 0.00% | – |
| Q1 2018 | $572,000 | +73.3% | 116,692 | 0.0% | 0.00% | – |
| Q4 2017 | $330,000 | +172.7% | 116,692 | +183.4% | 0.00% | – |
| Q3 2017 | $121,000 | -31.6% | 41,173 | -26.7% | 0.00% | – |
| Q2 2017 | $177,000 | -21.3% | 56,173 | 0.0% | 0.00% | – |
| Q1 2017 | $225,000 | -88.1% | 56,173 | -77.2% | 0.00% | -100.0% |
| Q4 2016 | $1,897,000 | -36.2% | 246,277 | -33.0% | 0.00% | -50.0% |
| Q3 2016 | $2,975,000 | +28.5% | 367,311 | -6.4% | 0.00% | +100.0% |
| Q2 2016 | $2,315,000 | -29.2% | 392,484 | -16.1% | 0.00% | -50.0% |
| Q1 2016 | $3,272,000 | -13.1% | 468,003 | -0.1% | 0.00% | 0.0% |
| Q4 2015 | $3,765,000 | -2.7% | 468,289 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $3,868,000 | -28.2% | 468,289 | +0.3% | 0.00% | -25.0% |
| Q2 2015 | $5,385,000 | -3.3% | 467,003 | +41.4% | 0.00% | 0.0% |
| Q1 2015 | $5,569,000 | +180.0% | 330,202 | +227.9% | 0.00% | +300.0% |
| Q4 2014 | $1,989,000 | – | 100,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |